Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)

The American Journal of Cardiology
Clyde W YancyMarc A Silver

Abstract

The Follow-Up Serial Infusions of Nesiritide pilot study was designed to assess the safety and tolerability of outpatient serial infusions of nesiritide in 210 patients with decompensated heart failure who were randomly assigned to usual care only or usual care plus weekly infusions of nesiritide at dosages of 0.005 or 0.01 microg/kg/min for 12 weeks. The mean age +/- SD of the entire population was 67 +/- 13 years; 70% were men, and 80% were white. Mean baseline serum creatinine levels were 1.8 +/- 0.7 mg/dl, and mean left ventricular ejection fraction was 0.28 +/- 0.15%. Diabetes mellitus was present in 106 patients (50%), and atrial arrhythmias were present in 100 patients (48%). A totalof 1,645 nesiritide infusions was administered; 11 (< 1%) were discontinued due to an adverse event. All treatment groups had a similar frequency of adverse events and experienced improvements in quality of life. Administration of nesiritide resulted in acute decreases in aldosterone and endothelin-1 concentrations. Although there were no statistically significant differences among groups by outcome, prospectively defined higher risk subgroups demonstrated significant decreases in cardiovascular events. These results demonstrate the safety an...Continue Reading

References

Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·N TamuraM Katsuki
Mar 28, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)

❮ Previous
Next ❯

Citations

Mar 3, 2009·Cardiovascular Drugs and Therapy·Ioannis D DontasLila Papadimitriou
Dec 20, 2008·Heart Failure Reviews·Marco MetraGad Cotter
Jun 23, 2011·Current Heart Failure Reports·Adam P PleisterGarrie J Haas
Dec 13, 2006·American Heart Journal·Rohit R AroraJanos Molnar
Sep 28, 2005·International Journal of Cardiology·Kazuki NakajimaTakeshi Nakano
Oct 7, 2009·Journal of Neurotrauma·Michael L JamesDaniel T Laskowitz
Feb 15, 2008·Critical Care Medicine·Kelly V LiangMargaret M Redfield
Feb 22, 2005·Congestive Heart Failure·Andrew J Burger
Mar 1, 2005·Future Cardiology·Robert E Hobbs, Wilson Tang
Sep 27, 2005·The Heart Surgery Forum·Nader Moazami, Mehmet C Oz
May 2, 2007·Current Cardiology Reports·Brian Hiestand, William T Abraham
Feb 9, 2010·Expert Review of Cardiovascular Therapy·Tracy A DeWald, Adrian F Hernandez
May 8, 2009·Expert Review of Cardiovascular Therapy·Michiko ShimadaThomas M Beaver
Jun 23, 2009·Expert Opinion on Drug Metabolism & Toxicology·Ann T Tong, Marc A Rozner
Jun 17, 2008·The American Journal of the Medical Sciences·Andreas SynetosStamatios Lerakis
Jul 15, 2006·Chest·Michael J AkermanJonathan D Marmur
Oct 30, 2007·Critical Care Clinics·James F Neuenschwander, Ragavendra R Baliga
Sep 11, 2007·Journal of Cardiac Failure·John L JefferiesJeffrey A Towbin
May 20, 2015·International Journal of Cardiology·Markku S NieminenRobert Zymliński
Feb 2, 2006·Fundamental & Clinical Pharmacology·Cédric Moro, Michel Berlan
Sep 27, 2006·Pharmacotherapy·Michael P Dorsch, Jo Ellen Rodgers
Dec 17, 2009·Clinical Cardiology·Santosh G MenonAndrew A Protter
Jan 3, 2006·Annals of Emergency Medicine·W Frank PeacockCharles Emerman
Sep 8, 2005·Expert Opinion on Pharmacotherapy·John V TerrovitisJohn N Nanas
Apr 2, 2013·Journal of the American College of Cardiology·Sean P CollinsMihai Gheorghiade
Nov 6, 2012·Journal of the American College of Cardiology·Horng H ChenJohn C Burnett
Feb 13, 2007·Journal of the American College of Cardiology·Robert M MentzerUNKNOWN NAPA Investigators
Nov 14, 2014·Current Heart Failure Reports·Emer Joyce, Anju Nohria
Oct 27, 2004·Expert Review of Cardiovascular Therapy·John V Wylie, Lana Tsao
Mar 28, 2007·Heart Failure Clinics·John C Burnett
Sep 19, 2007·Journal of Cardiovascular Pharmacology and Therapeutics·Ernst R SchwarzSalvatore Rosanio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.